MedTrace Logo

Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2

NCT01872286 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2014-03-03

No results posted yet for this study

Summary

Capsule endoscopy has been shown to be the first-line endoscopic procedure for small bowel disease. This study was aimed to compare the performance between the frequency-altering AKE-1 capsule and the Pillcam SB2 in patients with suspected small bowel disease.

Conditions

  • Intestinal Diseases
  • Gastrointestinal Hemorrhage

Interventions

DEVICE

AKE-1

DEVICE

Pillcam SB2

Sponsors & Collaborators

  • Second Military Medical University

    collaborator OTHER

  • Ministry of Education, China

    collaborator OTHER_GOV

  • Changhai Hospital

    lead OTHER

Principal Investigators

  • Zhao-Shen Li, Dr. · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2012-12-31
Completion
2013-02-28

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01872286 on ClinicalTrials.gov